Overview
- Editors:
-
-
Maurice L. Slevin
-
Department of Medical Oncology, St Bartholomew’s Hospital, West Smithfield, London, UK
-
Teresa Tate
-
Department of Medical Oncology, St Bartholomew’s Hospital, West Smithfield, London, UK
- Examines the three main treatment modalities: surgery, radiotherapy and chemotherapy
- Authoritative contributors provide a comprehensive overview of the topic
- Fills an important gap in the available literature
Access this book
Other ways to access
Table of contents (20 chapters)
-
Front Matter
Pages i-xvii
-
Non-Curative Surgery
-
-
- Jonathan D. Harrison, John W. L. Fielding
Pages 3-24
-
- S. J. Watson, R. J. Nicholls
Pages 25-54
-
- John H. Shepherd, Robin Crawford
Pages 55-63
-
-
- D. G. Porter, D. G. T. Thomas
Pages 71-82
-
- Ugo Pastorino, Peter Goldstraw
Pages 83-101
-
Non-Curative Radiotherapy
-
Front Matter
Pages 103-103
-
- D. J. Boote, N. M. Bleehen
Pages 105-111
-
- M. E. B. Powell, P. J. Hoskin
Pages 113-127
-
- D. J. Sebag-Montefiore, S. J. Arnott
Pages 129-139
-
- D. J. Sebag-Montefiore, S. J. Arnott
Pages 141-146
-
-
- R. Barton, L. Brazil, Michael Brada
Pages 159-172
-
- Gillian M. Sadler, Jeffrey S. Tobias
Pages 173-185
-
Non-Curative Chemotherapy
-
Front Matter
Pages 187-187
-
-
- C. M. McLean, R. C. F. Leonard
Pages 199-214
-
About this book
Cancer is a major issue in the provision of health care. It is estimated that one in four people in developed countries are likely to develop it at some time. As longevity steadily increases, the incidence of malignant disease is expected to rise further. Important advances in the control of cancer have taken place and curative treatment has improved, notably in some of the rarer tumours, particularly in children. Advances in the more common cancers have been less marked, although adjunctive systemic treatment and population screening are lowering mortality from the most prevalent cance- carcinoma of the breast. Despite this progress, complete control of malignant disease is still a long way off. However, our understanding of the molecular biology of cancer has increased enormously in recent years and the application of this knowledge holds considerable promise for developing new therapeutic strategies. As for prevention, the cause of most cancers is still poorly understood although it is clear that tobacco avoidance would prevent most lung cancers and several others. Cancer is studied at many different levels: molecular and cellular biology, pathology in patients (particularly clinical trials), and prevention and populations (epidemiology). The psychosocial problems caused to patients and their families are being increasingly recognized and subjected to systematic study. Workers in the field, therefore, range from basic scientists to epidemiologists, from hospital specialists to community support teams. Each needs to have at least some knowledge of the role the others play.